Article content material AMSTERDAM, ZUG, Switzerland & GDAŃSK, Poland — Polpharma Biologics S.A. (“Polpharma Biologics”) broadcasts a world (aside from…
Read More
STAT+: Brawl over Eylea will get biosimilar trade’s consideration
Wish to keep on prime of the science and politics driving biotech at present? Join to get our biotech publication in your…
Read More
Teva receives FDA approval for biosimilar
Up to date 18.42 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported that the FDA has…
Read More
